NCT03202875View on ClinicalTrials.gov

A Study to Compare Pharmacokinetics (PK) and Pharmacodynamics (PD) of SAR341402 to Insulin Aspart in Subjects With Type 1 Diabetes Mellitus

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 14, 2012

Primary Completion Date

December 28, 2012

Study Completion Date

December 28, 2012

Conditions
Type 1 Diabetes
Interventions
DRUG

SAR341402

"Pharmaceutical form: solution~Route of administration: subcutaneous"

DRUG

Insulin Aspart

"Pharmaceutical form: solution~Route of administration: subcutaneous"

DRUG

Insulin Aspart

"Pharmaceutical form: solution~Route of administration: subcutaneous"

Trial Locations (1)

Unknown

Investigational Site 276001, Neuss

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY